Mette Kirstine Agger

Mette Kirstine Agger is a Managing Partner at Lundbeckfonden Ventures. She is a board member of Cydan Development, Imara, LEXEO Therapeutics, Psioxus, scPharmaceuticals and Tiburio Therapeutics. Ms. Agger has a broad international experience within biotech and life sciences, covering business development and licensing, management and financing and has been appointed to numerous board positions in both private and public companies. She was previously co-founder and CEO of 7TM Pharma A/S. Prior to founding 7TM Pharma, Ms. Agger was part of the management team of Neuro Search A/S, responsible for business development and licensing. She started her career as a patent agent and, over the years, has co-founded several biotech companies. Ms. Agger graduated as a biologist from the University of Copenhagen and holds an MBA from Henley Business School.